Ingen internetforbindelse — viser den gemte version af siden.

BIOMERIEUX

FREUR
← Til Screeneren

BIOMERIEUX (US:BMXMF) — Diagnostics & Research. Antal børser, hvor selskabets aktier handles: 4. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
biomerieux.fr
Sektor
Healthcare · Diagnostics & Research
Hovedkontor
Marcy-l'Étoile, France
Administrerende Direktør
Pierre Boulud
Ansatte
14 562
Grundlagt
1963
Udestående Aktier
117.95 mio.
Free Float
40.02 mio.
Markedsværdi
9.17 mia. EUR
Insidere
66.46%
Institutionelle Investorer
16.73%
Juridisk Form
K65D
ISIN
FR0013280286
LEI
549300AK8Y0LBIQ4T071
Udbetalingsgrad
24.9%
FCF
586 mio. EUR
Udbetaling / FCF
20%
Gæld
422 mio. EUR
0.0 år FCF
Udbyttestreak
21 år
Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 30.06.2026 (selskabets seneste rapport).
Beskrivelse

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of an antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. operates as a subsidiary of Institut Mérieux SA.

annonce

Børser og Tickere

BørsTickerValutaPrisType
PA Euronext ParisBIM primærEUR87.4 +2.04%almindelige aktier
LSE London Stock Exchange0RUG IOBEUR104.4 +0.00%almindelige aktier
US USA StocksBMXMF OTCUSD95 +4.00%almindelige aktier
VI Vienna Stock ExchangeBIM sekundærEUR81 +1.44%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Pr. År, US:BMXMF: 0.98 EUR (1 udb.)

BIOMERIEUX (BMXMF) udbetaler udbytte én gang om året. Pr. År (12 måneder op til og med den senest annoncerede betaling): 0.98 EUR pr. Aktie (betalinger: 1). Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 10.06.2027. Uafbrudt udbyttehistorik: 21 år.

Ex-DatoUdbetalingBeløb%TypeTicker
2026-06-102026-06-110.9800 EUR1.3/1.3 %årligUS:BMXMF
2025-06-102025-06-110.9000 EUR0.7/0.7 %årligUS:BMXMF
2024-06-102024-06-110.8500 EUR0.9/0.9 %årligUS:BMXMF

Største Ejere

EjerAndelAktierRapportdato
New Economy Fund0.86%1.02 mio.2026-06-30
VANGUARD STAR FUNDS-Vang…0.54%638 3802026-04-30
Tweedy, Browne Fund Inc.…0.41%481 7312026-06-30
VANGUARD TAX-MANAGED FUN…0.32%384 5602026-06-30
iShares Trust-iShares Co…0.26%304 3802026-07-31
AMERICAN FUNDS INSURANCE…0.19%226 5732026-06-30
Fidelity Concord Street…0.13%149 0192026-07-31
Bridge Builder Trust-Bri…0.12%142 4212026-06-30
iShares Trust-iShares MS…0.12%142 2442026-07-31
DFA INVESTMENT TRUST CO-…0.09%109 8292026-04-30
Pacer Advisors, Inc.0%2022026-06-30